9. Mori H, Fukuhara T (Corresponding author), Ono C, Tamura T, Sato A, Fauzyah Y, Wada M, Okamoto T, Noda T, Yoshimori T and Matsuura Y. (2018) Induction of selective autophagy in cells replicating hepatitis C virus genome. J Gen Virol. 99(12): 1643-57, 2018
8. Suda T, Tatsumi T, Nishio A, Kegasawa T, Yoshioka T, Yamada R, Furuta K, Kodama T, Shigekawa M, Hikita H, Sakamori R, Fukuhara T, Matsuura Y and Takehara T. CEACAM1 is associated with the suppression of natural killer cell function in patients with chronic hepatitis C. Hepatol Commun. 2(10): 1247-58, 2018
7. Suzuki T, Okamoto T, Katoh H, Sugiyama Y, Kusakabe S, Tokunaga M, Hirano J, Miyata Y, Fukuhara T, Ikawa M, Satoh T, Yoshio S, Suzuki R, Saijo M, Huang DCS, Kanto T, Akira S and Matsuura Y. Infection with flaviviruses requires BCLXL for cell survival. PLoS Pathog. 14(9): e1007299, 2018
6. Harada N, Yoshizumi T, Ikegami T, Itoh S, Furusho N, Kato M, Shimoda S, Fukuhara T, Soejima Y and Maehara Y. Serum Asunaprevir and Daclatasvir concentrations and outcomes in patients with recurrent hepatitis C who have undergone living donor liver transplantation. Anticancer Res. 38(9): 5513-5520, 2018
5. Okai K, Ichikawa-Tomikawa N, Saito AC, Watabe T, Sugimoto K, Fujita D, Ono C, Fukuhara T, Matsuura Y, Ohira H and Chiba H. A novel occludin-targeting monoclonal antibody prevents hepatitis C virus infection in vitro. Oncotarget. 9(24): 16588-98, 2018
4. Tanaka T, Otoguro T, Yamashita A, Kasai H Fukuhara T, Matsuura Y and Moriishi K. Roles of the 5′ untranslated region of nonprimate hepacivirus in translation initiation and viral replication. J Virol. 92(7): e01997-17, 2018
3. Tamura T, Fukuhara T (Corresponding author), Uchida T, Ono C, Mori H, Sato A, Fauzyah Y, Okamoto T, Kurosu T, Setoh YX, Imamura M, Tautz N, Sakoda Y, Khromykh AA, Chayama K and Matsuura Y. Characterization of recombinant Flaviviridae viruses possessing a small reporter tag. J Virol. 92(2): e01582-17, 2018
2. Shimizu K (Corresponding author), Yoshimatsu K, Taruishi M, Tsuda Y and Arikawa J. Involvement of CD8+ T cells in the development of renal hemorrhage in a mouse model of hemorrhagic fever with renal syndrome. Arch Virol. 163(6): 1577-1584, 2018
1. Lundu T, Tsuda Y, Ito R, Shimizu K, Kobayashi S, Yoshii K, Yoshimatsu K, Arikawa J and Kariwa H. Targeting of severe fever with thrombocytopenia syndrome virus structural proteins to the ERGIC (endoplasmic reticulum Golgi intermediate compartment) and Golgi complex. Biomed Res-Tokyo. 39(1): 27-38, 2018